Lv T - Search Results

1

Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from China.

Chen S, Duan W, Li M, Li S, Lv T, Tian Q, Wang Q, Wu X, Zhao X, Wang X, Wang Y, Kong Y, Ma H, Ou X, You H, Jia J. Chen S, et al. Among authors: lv t. J Gastroenterol Hepatol. 2019 Jul;34(7):1236-1241. doi: 10.1111/jgh.14521. Epub 2018 Nov 14. J Gastroenterol Hepatol. 2019. PMID: 30365184

2

Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population.

Lv T, Li M, Zeng N, Zhang J, Li S, Chen S, Zhang C, Shan S, Duan W, Wang Q, Wu S, You H, Ou X, Ma H, Zhang D, Kong Y, Jia J. Lv T, et al. J Gastroenterol Hepatol. 2019 Oct;34(10):1676-1684. doi: 10.1111/jgh.14746. Epub 2019 Jul 7. J Gastroenterol Hepatol. 2019. PMID: 31146297

3

Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis.

Li M, Lv T, Wu S, Wei W, Wu X, Ou X, Ma H, Chow SC, Kong Y, You H, Jia J. Li M, et al. Among authors: lv t. Hepatol Int. 2020 Jan;14(1):105-114. doi: 10.1007/s12072-019-10005-0. Epub 2020 Jan 3. Hepatol Int. 2020. PMID: 31898210

4

Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis.

Lv T, Chen S, Li M, Zhang D, Kong Y, Jia J. Lv T, et al. J Gastroenterol Hepatol. 2021 Jun;36(6):1423-1434. doi: 10.1111/jgh.15329. Epub 2020 Dec 6. J Gastroenterol Hepatol. 2021. PMID: 33141955

5

Reciprocal alterations in circulating and hepatic gamma-delta T cells in patients with primary biliary cholangitis.

Chen S, Lv T, Sun G, Li S, Duan W, Zhang C, Jin H, Tian D, Li M, Shan S, Ma H, Ou X, You H, Zhang D, Jia J. Chen S, et al. Among authors: lv t. Hepatol Int. 2022 Feb;16(1):195-206. doi: 10.1007/s12072-021-10267-7. Epub 2022 Jan 14. Hepatol Int. 2022. PMID: 35028922

6

Rare liver diseases are not rare in China.

Lv T, Jia J. Lv T, et al. Liver Int. 2022 Aug;42(9):2023-2028. doi: 10.1111/liv.15267. Epub 2022 Apr 12. Liver Int. 2022. PMID: 35365968 Review.

7

The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC.

Duan W, Chen S, Li S, Lv T, Li B, Wang X, Wang Y, Zhao X, Ma H, Ou X, You H, Jia J. Duan W, et al. Among authors: lv t. Hepatol Commun. 2022 Nov;6(11):3112-3119. doi: 10.1002/hep4.2067. Epub 2022 Aug 23. Hepatol Commun. 2022. PMID: 35998274 Free PMC article.

8

Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis.

Chen S, Li MQ, Duan WJ, Li BE, Li SX, Lv TT, Ma L, Jia JD. Chen S, et al. Hepatobiliary Pancreat Dis Int. 2022 Dec;21(6):577-582. doi: 10.1016/j.hbpd.2022.05.009. Epub 2022 May 24. Hepatobiliary Pancreat Dis Int. 2022. PMID: 35668014

9

Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease.

Kong Y, Lv T, Li M, Zhao L, Meng T, Wu S, Wei W, Zhang Q, Chen S, You H, Lens S, Yoshiji H, Francque S, Tsochatzis E, Sarin SK, Mandorfer M, Jia J; BAVENO Cooperation: an EASL consortium. Kong Y, et al. Among authors: lv t. Hepatol Int. 2022 Oct;16(5):1052-1063. doi: 10.1007/s12072-022-10369-w. Epub 2022 Sep 9. Hepatol Int. 2022. PMID: 36083440

10

Hybrid metamaterial switching for manipulating chirality based on VO2 phase transition.

Lv TT, Li YX, Ma HF, Zhu Z, Li ZP, Guan CY, Shi JH, Zhang H, Cui TJ. Lv TT, et al. Sci Rep. 2016 Mar 22;6:23186. doi: 10.1038/srep23186. Sci Rep. 2016. PMID: 27000427 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,320 results

Search Page